Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TMSB4XP2 (TMSB4X pseudogene 2) is classified as a pseudogene related to the TMSB4X (thymosin beta-4 X-linked) gene. Pseudogenes are non-functional sequences similar to known genes but typically do not encode active proteins. TMSB4XP2 has no known function, no established role in disease, is not a therapeutic target, and is not involved in any known biological pathway[4].\n\nKey clarification:\nTMSB4XP2 should not be confused with TMSB4X (thymosin beta-4, X-linked), an actin-sequestering protein-coding gene implicated in cancer progression, wound healing, and angiogenesis[1][2][3]. All described biological roles and druggability for thymosin beta-4 refer to TMSB4X, not TMSB4XP2.\n\nIf further information on the functional gene (TMSB4X) is required, see TMSB4X and thymosin beta-4, not the pseudogene TMSB4XP2[1][2][3].
As a pseudogene, TMSB4XP2 has no mechanism of action for drugs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TMSB4X pseudogene 2 (TMSB4XP2).